{"id":1577,"date":"2026-03-12T15:15:26","date_gmt":"2026-03-12T15:15:26","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/03\/12\/new-european-patent-covers-all-dosing-regimens-of-experimental-ms-therapy\/"},"modified":"2026-03-12T15:15:26","modified_gmt":"2026-03-12T15:15:26","slug":"new-european-patent-covers-all-dosing-regimens-of-experimental-ms-therapy","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/03\/12\/new-european-patent-covers-all-dosing-regimens-of-experimental-ms-therapy\/","title":{"rendered":"New European patent covers all dosing regimens of experimental MS therapy"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/12\/new-european-patent-covers-all-regimens-ms-therapy-vidofludimus-calcium\/\" title=\"New European patent covers all dosing regimens of experimental MS therapy\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"526\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/03\/iStock-patent-800x526.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"Icons, including &quot;PATENTED&quot; and a copyright symbol, are superimposed over a close-up image of a person typing on a laptop keyboard.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"160351\" \/><\/a><\/p>\n<p>Immunic Therapeutics has been granted a new patent in Europe covering multiple dosing regimens of its experimental therapy vidofludimus calcium and related molecules for multiple sclerosis (MS) and other indications. The patent, titled &#8220;Dosage Regimen of Vidofludimus for Use in the Treatment of a Chronic Inflammatory and\/or Autoimmune Diseases,&#8221; covers all relevant dosing regimens of [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/12\/new-european-patent-covers-all-regimens-ms-therapy-vidofludimus-calcium\/\">New European patent covers all dosing regimens of experimental MS therapy<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/12\/new-european-patent-covers-all-regimens-ms-therapy-vidofludimus-calcium\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immunic Therapeutics has been granted a new patent in Europe covering multiple dosing regimens of its experimental therapy vidofludimus calcium and related molecules for multiple sclerosis (MS) and other indications. The patent, titled &#8220;Dosage Regimen of Vidofludimus for Use in the Treatment of a Chronic Inflammatory and\/or Autoimmune Diseases,&#8221; covers all relevant dosing regimens of&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1578,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1577","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1577"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1577\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1578"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}